CFO of 10x Genomics Inc (30-Year Financial, Insider Trades) Justin J. Mcanear (insider trades) sold 10,000 shares of TXG on 04/01/2020 at an average price of $58.09 a share. The total sale was $580,900.
10x Genomics Inc has a market cap of $5.67 billion; its shares were traded at around $58.69 with and P/S ratio of 16.37. GuruFocus has detected 1 severe warning sign with 10x Genomics Inc. .
CEO Recent Trades:
- CEO, 10% Owner Serge Saxonov sold 10,000 shares of TXG stock on 04/01/2020 at the average price of $58.07. The price of the stock has increased by 1.07% since.
- CEO, 10% Owner Serge Saxonov sold 10,000 shares of TXG stock on 03/06/2020 at the average price of $65.14. The price of the stock has decreased by 9.9% since.
CFO Recent Trades:
- CFO Justin J. Mcanear sold 10,000 shares of TXG stock on 04/01/2020 at the average price of $58.09. The price of the stock has increased by 1.03% since.
- CFO Justin J. Mcanear sold 10,000 shares of TXG stock on 03/06/2020 at the average price of $65.16. The price of the stock has decreased by 9.93% since.
Directors and Officers Recent Trades:
- See Remarks, 10% Owner Benjamin J. Hindson sold 33,750 shares of TXG stock on 04/01/2020 at the average price of $58.12. The price of the stock has increased by 0.98% since.
- Chief Commercial Officer Bradford Crutchfield sold 17,000 shares of TXG stock on 04/01/2020 at the average price of $58.06. The price of the stock has increased by 1.09% since.
- 10% Owner Capital Fund I, L.p. Foresite sold 750,000 shares of TXG stock on 03/17/2020 at the average price of $59. The price of the stock has decreased by 0.53% since.
- See Remarks, 10% Owner Benjamin J. Hindson sold 33,750 shares of TXG stock on 03/06/2020 at the average price of $65.59. The price of the stock has decreased by 10.52% since.
- Chief Commercial Officer Bradford Crutchfield sold 17,000 shares of TXG stock on 03/06/2020 at the average price of $65.91. The price of the stock has decreased by 10.95% since.
For the complete insider trading history of TXG, click here
.
